Clinical Trials
4 trialsNCT03361319 2020-11-24
N3
Royal Marsden NHS Foundation Trust
Phase 1/2 Withdrawn
NCT01610869 2019-05-29
METRO-BIBF
University College, London
Phase 2 Completed
NCT02558387 2015-11-20
Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck
Samsung Medical Center
Phase 2 Unknown
NCT01380782 2014-08-18
BIBF 1120 for Recurrent High-Grade Gliomas
Dana-Farber Cancer Institute
Phase 2 Completed